A Randomized Cohort Study: Is It Worth the Time to Receive Antiandrogenic Pretreatment Before Ovulation Induction for Women With Polycystic Ovary Syndrome?

    February 2022 in “ Frontiers in Endocrinology ”
    Zhiyan Chen, Jichun Tan, Huichun Wang, Baodong Zheng, Jian Liu, Guimin Hao, Zaixin Guo, Zhengyi Sun, Qi Yu
    Image of study
    TLDR Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.
    The study conducted in six centers across China involved 230 women with Polycystic Ovary Syndrome (PCOS) and hyperandrogenism. The participants were divided into two groups: one received immediate ovulation induction using letrozole (115 patients), and the other received antiandrogenic pretreatment using ethinylestradiol/cyproterone acetate (EE/CPA) for 3 months followed by ovulation induction using letrozole (115 patients). The final analysis included 166 participants, with 90 in the letrozole group and 76 in the EE/CPA+ letrozole group. The results showed no significant differences in cumulative ovulation, conception, ongoing pregnancy, and live birth rates between the two groups. However, the time taken to pregnancy was significantly longer in the EE/CPA+ letrozole group due to the extended 3 months of antiandrogen pretreatment. The study concluded that antiandrogenic pretreatment does not significantly improve ovulation induction outcomes but extends the time to pregnancy. Therefore, immediate ovulation induction is recommended for patients with conception plans.
    Discuss this study in the Community →

    Research cited in this study

    4 / 4 results

    Related Community Posts Join

    6 / 12 results

      community How does hair loss and recovery work?

      in Chat  12 upvotes 2 months ago
      Hair loss varies due to genetic sensitivity to DHT and other factors. Treatments discussed include finasteride, minoxidil, RU58841, and microneedling.

      community C’est terrible - at my wits end

      in Female  443 upvotes 1 year ago
      A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hair loss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.

      community Female, 30, PCOS diagnosis, MPB Norwood 2. Endo refuses to give anything other than Spironolactone. Feel like I’m at my wit’s end here.

      in Female  56 upvotes 1 year ago
      A 30-year-old female with PCOS and male pattern baldness is frustrated with her endocrinologist's recommendation of only Spironolactone and minoxidil, feeling that dutasteride, finasteride, and progesterone would be more effective. Other users suggest various online sources for treatments, warn against self-medicating due to potential risks, and recommend seeking a specialized endocrinologist or considering additional treatments like Inositol, Berberine, and dermaneedling.

      community Why balding gets worse in every generation?

      in Chat  81 upvotes 5 months ago
      Balding seems to worsen with each generation, possibly due to stress, diet, and environmental factors. The user started treatments like Minoxidil and finasteride.

    Similar Research

    5 / 1000+ results